EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8 + T Cells
Stairiker, Christopher J, Pfister, Sophia Xiao, Hendrickson, Eleanore, Yang, Wenjing, Xie, Tao, Lee, Catherine, Zhang, Haikuo, Dillon, Christopher, Thomas, Graham D, Salek-Ardakani, Shahram
Published in Frontiers in immunology (24.11.2021)
Published in Frontiers in immunology (24.11.2021)
Get full text
Journal Article
737 Inhibition of P21-activated kinase 4 (PAK4) reverts immune exclusion and restores anti-tumor immunity in the tumor microenvironment
Zhou, Yu 'Jerry', Chu, Gina, Hendrickson, Eleanore, Gullo-Brown, Johnni, Chavez, Brandy, McAlpine, Indrawan, Rui, Eugene, Doran, Shawn, Timofeevski, Sergei, Heyen, Jonathan, Kinong, Jennifer, Tang, Szu-Yu, Oyer, Jon, Rayannavar, Vinayak, Nager, Andrew, Ching, Keith, Shi, Stephanie, Bhadra, Rajarshi, Dillon, Christopher, Gururajan, Murali
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
Jensen-Pergakes, Kristen, Tatlock, John, Maegley, Karen A, McAlpine, Indrawan J, McTigue, Michele, Xie, Tao, Dillon, Christopher P, Wang, Yuli, Yamazaki, Shinji, Spiegel, Noah, Shi, Manli, Nemeth, Amy, Miller, Natalie, Hendrickson, Eleanore, Lam, Hieu, Sherrill, John, Chung, Chi-Yeh, McMillan, Elizabeth A, Bryant, Shannon Karlicek, Palde, Prakash, Braganza, John, Brooun, Alexei, Deng, Ya-Li, Goshtasbi, Vesta, Kephart, Susan E, Kumpf, Robert A, Liu, Wei, Patman, Ryan L, Rui, Eugene, Scales, Stephanie, Tran-Dube, Michelle, Wang, Fen, Wythes, Martin, Paul, Thomas A
Published in Molecular cancer therapeutics (01.01.2022)
Published in Molecular cancer therapeutics (01.01.2022)
Get full text
Journal Article
Abstract 1160: SAM competitive PRMT5 inhibitor PF06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance
Jensen-Pergakes, Kristen, Tatlock, John, Maegley, Karen, McAlpine, Indrawan, McTigue, Michele, Xie, Tao, Dillon, Christopher, Wang, Yuli, Yamazaki, Shinji, Spiegel, Noah, Shi, Manli, Nemeth, Amy, Miller, Natalie, Hendrickson, Eleanore, Lam, Hieu, Sherrill, John, Liu, Wei, Deng, Ya-Li, Chung, Chi-Yeh, McMillan, Elizabeth A., Palde, Prakash, Brooun, Alexei, Braganza, John, Kephart, Susan E., Kumpf, Robert, Patman, Ryan, Rui, Eugene, Scales, Stephanie, Tran-Dube, Michelle, Wang, Fen, Wythes, Martin, Paul, Thomas
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article